After 14 days of treatment with bevacizumab (a VEGF inhibitor) and doxycycline (a drug which could inhibit angiogenesis as effectively as MMP-9 inhibitors), the tumor volume in pancreatic cancer mice was significantly reduced. This evidence concerns the gene VEGFA and pancreatic neoplasm.